Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and Efficacy of Prolonged Use of Dalbavancin in Bone and Joint Infections.
Morata L, Cobo J, Fernández-Sampedro M, Guisado Vasco P, Ruano E, Lora-Tamayo J, Sánchez Somolinos M, González Ruano P, Rico Nieto A, Arnaiz A, Estébanez Muñoz M, Jiménez-Mejías ME, Lozano Serrano AB, Múñez E, Rodriguez-Pardo D, Argelich R, Arroyo A, Barbero JM, Cuadra F, Del Arco A, Del Toro MD, Guio L, Jimenez-Beatty D, Lois N, Martin O, Martínez Alvarez RM, Martinez-Marcos FJ, Porras L, Ramírez M, Vergas García J, Soriano A. Morata L, et al. Antimicrob Agents Chemother. 2019 Apr 25;63(5):e02280-18. doi: 10.1128/AAC.02280-18. Print 2019 May. Antimicrob Agents Chemother. 2019. PMID: 30858217 Free PMC article.
[Curative treatment with fluconazole in 5 cases of invasive candidiasis].
Martínez-Marcos FJ, Jiménez-Mejías ME, Moreno-Maqueda I, Caballero-Granado J, Rodríguez-Hernández MJ, Pachón-Díaz J. Martínez-Marcos FJ, et al. Enferm Infecc Microbiol Clin. 1996 Nov;14(9):541-4. Enferm Infecc Microbiol Clin. 1996. PMID: 9035711 Spanish.
Neurocognitive safety after 96 weeks on dual therapy with atazanavir/ritonavir plus lamivudine: results of the neurocognitive substudy of the SALT randomized clinical trial.
Pérez-Valero I, Pasquau J, Rubio R, Rivero A, Santos J, Sanz J, Mariño A, Crespo M, Hernández-Quero J, Iribarren JA, Gutiérrez F, Terrón A, Esteban H, Pérez-Molina JA; GESIDA 7011 Study Group members. Pérez-Valero I, et al. J Antimicrob Chemother. 2018 Sep 1;73(9):2444-2451. doi: 10.1093/jac/dky212. J Antimicrob Chemother. 2018. PMID: 29897573 Free article. Clinical Trial.
DALBACEN cohort: dalbavancin as consolidation therapy in patients with endocarditis and/or bloodstream infection produced by gram-positive cocci.
Hidalgo-Tenorio C, Vinuesa D, Plata A, Martin Dávila P, Iftimie S, Sequera S, Loeches B, Lopez-Cortés LE, Fariñas MC, Fernández-Roldan C, Javier-Martinez R, Muñoz P, Arenas-Miras MDM, Martínez-Marcos FJ, Miró JM, Herrero C, Bereciartua E, De Jesus SE, Pasquau J. Hidalgo-Tenorio C, et al. Ann Clin Microbiol Antimicrob. 2019 Oct 19;18(1):30. doi: 10.1186/s12941-019-0329-6. Ann Clin Microbiol Antimicrob. 2019. PMID: 31629409 Free PMC article.
EN-DALBACEN 2.0 Cohort: real-life study of dalbavancin as sequential/consolidation therapy in patients with infective endocarditis due to Gram-positive cocci.
Hidalgo-Tenorio C, Sadyrbaeva-Dolgova S, Enríquez-Gómez A, Muñoz P, Plata-Ciezar A, Miró JM, Alarcón A, Martínez-Marcos FJ, Loeches B, Escrihuela-Vidal F, Vinuesa D, Herrero C, Boix-Palop L, Del Mar Arenas M, Vázquez EG, de Las Revillas FA, Pasquau J; EN-DALBACEN study group. Hidalgo-Tenorio C, et al. Among authors: martinez marcos fj. Int J Antimicrob Agents. 2023 Sep;62(3):106918. doi: 10.1016/j.ijantimicag.2023.106918. Epub 2023 Jul 11. Int J Antimicrob Agents. 2023. PMID: 37442488 Free article.
Infective endocarditis caused by penicillin-resistant viridans group streptococci: a series of nine cases from a Spanish cohort.
Escrihuela-Vidal F, Fernández-Hidalgo N, Muñoz P, Villamarín M, Jiménez García N, Escudero EM, Martínez Marcos FJ, Cuervo G, Boix-Palop L, Berbel D, Carratalà J, Miró JM. Escrihuela-Vidal F, et al. Among authors: martinez marcos fj. J Antimicrob Chemother. 2024 Dec 2;79(12):3230-3235. doi: 10.1093/jac/dkae345. J Antimicrob Chemother. 2024. PMID: 39351977
Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial.
Perez-Molina JA, Rubio R, Rivero A, Pasquau J, Suárez-Lozano I, Riera M, Estébanez M, Santos J, Sanz-Moreno J, Troya J, Mariño A, Antela A, Navarro J, Esteban H, Moreno S; GESIDA 7011 Study Group. Perez-Molina JA, et al. Lancet Infect Dis. 2015 Jul;15(7):775-84. doi: 10.1016/S1473-3099(15)00097-3. Epub 2015 Jun 7. Lancet Infect Dis. 2015. PMID: 26062881 Clinical Trial.
Clinical and prognostic differences between methicillin-resistant and methicillin-susceptible Staphylococcus aureus infective endocarditis.
Hidalgo-Tenorio C, Gálvez J, Martínez-Marcos FJ, Plata-Ciezar A, De La Torre-Lima J, López-Cortés LE, Noureddine M, Reguera JM, Vinuesa D, García MV, Ojeda G, Luque R, Lomas JM, Lepe JA, de Alarcón A. Hidalgo-Tenorio C, et al. BMC Infect Dis. 2020 Feb 21;20(1):160. doi: 10.1186/s12879-020-4895-1. BMC Infect Dis. 2020. PMID: 32085732 Free PMC article.
Early Use of Sarilumab in Patients Hospitalized with COVID-19 Pneumonia and Features of Systemic Inflammation: the SARICOR Randomized Clinical Trial.
Merchante N, Cárcel S, Garrido-Gracia JC, Trigo-Rodríguez M, Moreno MÁE, León-López R, Espíndola-Gómez R, Alonso EA, García DV, Romero-Palacios A, Pérez-Camacho I, Gutiérrez-Gutiérrez B, Martínez-Marcos FJ, Fernández-Roldán C, Pérez-Crespo PMM, Caño AA, León E, Corzo JE, de la Fuente C, Torre-Cisneros J. Merchante N, et al. Antimicrob Agents Chemother. 2022 Feb 15;66(2):e0210721. doi: 10.1128/AAC.02107-21. Epub 2021 Dec 13. Antimicrob Agents Chemother. 2022. PMID: 34902262 Free PMC article. Clinical Trial.
58 results